Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Enveric Biosciences, Inc. ENVB

Full chart Compare
Set alert

Price alert · ENVB

All alert types
1.50 USD 0.00 (+0.00%)

Nov 4, 2026, 10:22 AM EST

1.49 Day range 1.58
1.27 52-week range 10.33
YTD
-58.68%
1 year
-73.68%

Financial health

Altman Z-Score

-16.19 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -0.1×
FY 2016: -459×FY 2017: -76.8×FY 2018: -3.7×FY 2019: -32.0×FY 2020: -57.6×FY 2021: -6.7×FY 2022: -2.4×FY 2023: -2.4×FY 2024: -0.3×FY 2025: -0.1×
FY 2016 5y median -2.4× FY 2025
P/S 0.0×
FY 2016: 35.3×FY 2017: 14.4×FY 2018: 1.4×FY 2019: 4.5×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.3×
FY 2016: 110×FY 2017: 35.9×FY 2018: 5.8×FY 2019: 16.9×FY 2020: 108×FY 2021: 14.8×FY 2022: 4.4×FY 2023: 21.5×FY 2024: 1.7×FY 2025: 0.3×
FY 2016 5y median 4.4× FY 2025
P/FCF -0.1×
FY 2016: -200×FY 2017: -254×FY 2018: -24.2×FY 2019: -277×FY 2020: -93.5×FY 2021: -26.7×FY 2022: -3.7×FY 2023: -3.0×FY 2024: -0.4×FY 2025: -0.1×
FY 2016 5y median -3.0× FY 2025
EV/EBITDA 0.4×
FY 2016: -290×FY 2017: -91.2×FY 2018: -9.5×FY 2019: -81.3×FY 2020: -58.1×FY 2021: -5.6×FY 2022: -2.4×FY 2023: -2.4×FY 2024: -0.1×FY 2025: 0.4×
FY 2016 5y median -2.4× FY 2025
EV/Sales 0.0×
FY 2016: 35.4×FY 2017: 14.4×FY 2018: 1.5×FY 2019: 4.6×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -670.1%
FY 2016: -0.5%FY 2017: -0.4%FY 2018: -4.1%FY 2019: -0.4%FY 2020: -1.1%FY 2021: -3.7%FY 2022: -27.3%FY 2023: -33.5%FY 2024: -285.6%FY 2025: -670.1%
FY 2016 5y median -33.5% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 18.1%FY 2017: 21.1%FY 2018: 20.9%FY 2019: 20.4%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -14.9%FY 2017: -24.6%FY 2018: -16.6%FY 2019: -15.8%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -7.7%FY 2017: -18.7%FY 2018: -39.3%FY 2019: -14.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -290.4%
FY 2016: -23.8%FY 2017: -46.7%FY 2018: -157.1%FY 2019: -52.8%FY 2020: -201.0%FY 2021: -219.6%FY 2022: -126.1%FY 2023: -0.9%FY 2024: -601.1%FY 2025: -290.4%
FY 2016 5y median -219.6% FY 2025
ROIC -210.0%
FY 2016: -7.6%FY 2017: -35.6%FY 2018: -35.5%FY 2019: -40.8%FY 2020: -164.5%FY 2021: -91.0%FY 2022: -118.3%FY 2023: -840.8%FY 2024: -604.7%FY 2025: -210.0%
FY 2016 5y median -210.0% FY 2025
ROA -238.1%
FY 2016: -7.0%FY 2017: -17.4%FY 2018: -57.0%FY 2019: -22.4%FY 2020: -167.6%FY 2021: -183.3%FY 2022: -94.6%FY 2023: -0.4%FY 2024: -310.6%FY 2025: -238.1%
FY 2016 5y median -183.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 126.2%FY 2017: 34.4%FY 2018: -11.5%FY 2019: -7.2%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 8.9%
FY 2016: -187.6%FY 2017: -122.5%FY 2018: 40.3%FY 2019: 11.5%FY 2020: 11.2%FY 2021: -361.9%FY 2022: 23.1%FY 2023: 17.6%FY 2024: 41.4%FY 2025: 8.9%
FY 2016 FY 2025
EPS (diluted) 84.1%
FY 2016: -24.9%FY 2017: -184.6%FY 2018: -17.2%FY 2019: 94.0%FY 2020: 73.8%FY 2021: -86.8%FY 2022: 87.5%FY 2023: 37.8%FY 2024: -135.4%FY 2025: 84.1%
FY 2016 FY 2025
Free Cash Flow -5.4%
FY 2016: -19.3%FY 2017: 57.1%FY 2018: 6.6%FY 2019: 74.7%FY 2020: -507.1%FY 2021: -213.3%FY 2022: -43.9%FY 2023: 20.5%FY 2024: 45.2%FY 2025: -5.4%
FY 2016 FY 2025

Financial Health

Current Ratio 5.4×
FY 2016: 0.8×FY 2017: 0.5×FY 2018: 0.7×FY 2019: 0.5×FY 2020: 3.3×FY 2021: 8.5×FY 2022: 4.6×FY 2023: 1.5×FY 2024: 1.8×FY 2025: 5.4×
FY 2016 5y median 4.6× FY 2025
Quick Ratio 5.4×
FY 2016: 0.8×FY 2017: 0.5×FY 2018: 0.7×FY 2019: 0.5×FY 2020: 3.3×FY 2021: 8.5×FY 2022: 4.6×FY 2023: 1.5×FY 2024: 1.8×FY 2025: 5.4×
FY 2016 5y median 4.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.4×FY 2017: 0.4×FY 2018: 0.5×FY 2019: 0.5×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: -0.8×FY 2017: -0.3×FY 2018: -0.6×FY 2019: -2.0×FY 2020: 0.3×FY 2021: 0.3×FY 2022: 0.9×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.5×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -82778×
FY 2016: -7.2×FY 2017: -20.8×FY 2018: -9.8×FY 2019: -9.2×FY 2020: -12.6×FY 2021: -2515×FY 2022: -3803×FY 2023: -4436×FY 2024: 0.0×FY 2025: -82778×
FY 2016 5y median -3803× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 299.5%FY 2018: 3361132.7%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: -23021.4%FY 2018: -12363657.5%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31